Diagnostic validity of the chemiluminescent method compared to polymerase chain reaction for hepatitis B virus detection in the routine clinical diagnostic laboratory
- PMID: 24949287
- PMCID: PMC4063113
- DOI: 10.4103/2277-9175.133178
Diagnostic validity of the chemiluminescent method compared to polymerase chain reaction for hepatitis B virus detection in the routine clinical diagnostic laboratory
Abstract
Background: Hepatitis B virus (HBV) is the most common significant chronic viral infection world-wide. Hepatitis B surface antigen (HBsAg) has been the principal target for laboratory testing to identify active infection by HBV. We aimed to find out diagnostic validity of the Liaison chemiluminescent method compared to the polymerase chain reaction (PCR) method for HBV detection in the routine clinical diagnostic laboratory.
Materials and methods: From 350 patients suspicious of having infection with HBV, serum samples were separated and used for testing HBsAg by two methods of Liaison chemiluminescent immunoassay, with HBsAg confirmatory test and PCR method.
Results: According to the PCR results as assumed as gold standard method with 100% sensitivity and specificity, detection rate sensitivity of chemiluminescent with confirmatory test was 96% and its specificity was 100%, and for chemiluminescent without confirmatory test sensitivity and specificity were 100% and 70%, respectively. Also for chemiluminescent with confirmatory test, positive predictive value (PPV) was 100% and its negative predictive value (NPV) was 97%, compared to chemiluminescent without confirmatory test with PPV and NPV equal to 71% and 100%, respectively.
Conclusions: It is possible to conclude that in the majority of the HBV cases, the diagnostic value of chemiluminescent method compared to the PCR method is acceptable, except in low indexes positive cases that need further investigation with the PCR method.
Keywords: Chemiluminescent; diagnostic value; hepatitis B virus; polymerase chain reaction.
Conflict of interest statement
Similar articles
-
A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.Transfusion. 2009 Mar;49(3):585-95. doi: 10.1111/j.1537-2995.2008.02026.x. Epub 2008 Dec 12. Transfusion. 2009. PMID: 19192255
-
Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.Transfusion. 2004 Sep;44(9):1332-9. doi: 10.1111/j.1537-2995.2004.04055.x. Transfusion. 2004. PMID: 15318857
-
Application of sequential serological testing strategy for detection of Hepatitis B surface antigen (HBsAg) for diagnosing HBV infection.J Virol Methods. 2019 Dec;274:113726. doi: 10.1016/j.jviromet.2019.113726. Epub 2019 Aug 31. J Virol Methods. 2019. PMID: 31479692
-
Evaluation of the analytical performance of six rapid diagnostic tests for the detection of viral hepatitis B and C in Lubumbashi, Democratic Republic of Congo.J Virol Methods. 2020 Nov;285:113961. doi: 10.1016/j.jviromet.2020.113961. Epub 2020 Aug 26. J Virol Methods. 2020. PMID: 32860797
-
New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.Mol Diagn Ther. 2006;10(2):77-91. doi: 10.1007/BF03256447. Mol Diagn Ther. 2006. PMID: 16669606 Review.
Cited by
-
Detection technology and clinical applications of serum viral products of hepatitis B virus infection.Front Cell Infect Microbiol. 2024 Jul 5;14:1402001. doi: 10.3389/fcimb.2024.1402001. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39035352 Free PMC article. Review.
-
Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis.BMC Infect Dis. 2017 Nov 1;17(Suppl 1):698. doi: 10.1186/s12879-017-2772-3. BMC Infect Dis. 2017. PMID: 29143619 Free PMC article.
-
Performance evaluation of immunoassay for infectious diseases on the Alinity i system.J Clin Lab Anal. 2021 Mar;35(3):e23671. doi: 10.1002/jcla.23671. Epub 2020 Dec 7. J Clin Lab Anal. 2021. PMID: 33283340 Free PMC article.
-
Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection.J Immunol Res. 2022 Apr 13;2022:1372705. doi: 10.1155/2022/1372705. eCollection 2022. J Immunol Res. 2022. PMID: 35465353 Free PMC article. Review.
-
Detection of hepatitis B virus infection: A systematic review.World J Hepatol. 2015 Oct 18;7(23):2482-91. doi: 10.4254/wjh.v7.i23.2482. World J Hepatol. 2015. PMID: 26483870 Free PMC article.
References
-
- Jahani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine. 2003;21:1948–51. - PubMed
-
- Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008;14:858–66. - PubMed
-
- Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, et al. NIH consensus development statement on management of hepatitis B. NIH Consens State Sci Statements. 2008;25:1–29. - PubMed
-
- Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18(Suppl 1):S20–2. - PubMed
-
- Bhattacharya S, O’Donnell K, Dudley T, Kennefick A, Osman H, Boxall E, et al. Ante-natal screening and post-natal follow-up of hepatitis B in the West Midlands of England. QJM. 2008;101:307–12. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources